GSK3B and Parkinson disease: Given that small molecule inhibitors of GSK3B and activators of AKT1 have been reported to possess protective effects in experimental models of PD (48, 53), fisetin could be a promising neuroprotective agent for PD due to its ability to inhibit GSK3B or activate AKT1.